Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationship between health-related quality-of-life and functional outcome 6 months after moderate to severe TBI.
Cinotti R, Roquilly A, Chopin A, Martin FP, Morato Y, Lerebourg C, Moyer JD, Huet O, Lasocki S, Cohen B, Dahyot-Fizelier C, Chalard K, Seguin P, Chenet A, Perrouin-Verbe B, Sinha D, Asehnoune K, Feuillet F, Sébille V; Atlanréa Group and the SFAR Research Network. Cinotti R, et al. Ann Phys Rehabil Med. 2023 Jun;66(5):101715. doi: 10.1016/j.rehab.2022.101715. Epub 2023 Jan 16. Ann Phys Rehabil Med. 2023. PMID: 36652785 Free article. No abstract available.
Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.
Karsenty G, Denys P, Amarenco G, De Seze M, Gamé X, Haab F, Kerdraon J, Perrouin-Verbe B, Ruffion A, Saussine C, Soler JM, Schurch B, Chartier-Kastler E. Karsenty G, et al. Eur Urol. 2008 Feb;53(2):275-87. doi: 10.1016/j.eururo.2007.10.013. Epub 2007 Oct 16. Eur Urol. 2008. PMID: 17988791 Review.
Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.
Gamé X, Mouracade P, Chartier-Kastler E, Viehweger E, Moog R, Amarenco G, Denys P, De Seze M, Haab F, Karsenty G, Kerdraon J, Perrouin-Verbe B, Ruffion A, Soler JM, Saussine C. Gamé X, et al. J Pediatr Urol. 2009 Jun;5(3):156-64. doi: 10.1016/j.jpurol.2009.01.005. Epub 2009 Mar 4. J Pediatr Urol. 2009. PMID: 19264554 Review.
[Sexuality of women with neurologic disorders].
Perrouin-Verbe B, Courtois F, Charvier K, Giuliano F. Perrouin-Verbe B, et al. Prog Urol. 2013 Jul;23(9):594-600. doi: 10.1016/j.purol.2013.01.004. Epub 2013 Mar 7. Prog Urol. 2013. PMID: 23830253 Review. French.
Résultats du changement de marque de toxine botulinique de type A (TBA), Botox(®) vers Dysport(®), dans le traitement de l'hyperactivité détrusorienne neurogène (HDN).
Bottet F, Peyronnet B, Game X, Manunta A, Ruffion A, Perrouin-Verbe B, Reiss B, Previnaire J, Tournebise H, Bernuz B, Lenne K, Lechevallier E, Karsenty G. Bottet F, et al. Prog Urol. 2015 Nov;25(13):737. doi: 10.1016/j.purol.2015.08.043. Prog Urol. 2015. PMID: 26544238 French. No abstract available.
122 results